Lack of association between serum uric acid levels and outcome in acute ischemic stroke

Journal of the Neurological Sciences

Volumn 319, Issue 1-2, 2012, Pages 51-55

  Miedema, Irene ^a   Uyttenboogaart, Maarten ^a   Koch, Marcus ^b   Kremer, Berry ^a   De Keyser, Jacques ^c   Luijckx, Gert Jan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Acute ischemic stroke; Functional outcome; Neurological recovery; Uric acid

Indexed keywords

LUBELUZOLE; URIC ACID;

AGED; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; CONTROLLED STUDY; CONVALESCENCE; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; STROKE; URIC ACID;

EID: 84862758726     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.05.019     Document Type: Article

References (22)

1. Dimitroula HV, Hatzitolios AI, Karvounis HI. The role of uric acid in stroke: the issue remains unresolved. Neurologist Jul 2008;14(4):238-42.
2. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum Jul 15 2009;61(7):885-92.
3. Becker BF. Towards the physiological function of uric acid. Free Radic Biol Med Jun 1993;14(6):615-31. (Pubitemid 23172569)
4. Waring WS. Uric acid: an important antioxidant in acute ischaemic stroke. QJM Oct 2002;95(10):691-3. (Pubitemid 35203638)
5. Cherubini A, Ruggiero C, Polidori MC, Mecocci P. Potential markers of oxidative stress in stroke. Free Radic Biol Med Oct 1 2005;39(7):841-52.
6. Waring WS, Webb DJ, Maxwell SR. Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J Cardiovasc Pharmacol Sep 2001;38(3):365-71. (Pubitemid 32769556)
7. Romanos E, Planas AM, Amaro S, Chamorro A. Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke. J Cereb Blood Flow Metab Jan 2007;27(1):14-20. (Pubitemid 46006580)
8. Yu ZF, Bruce-Keller AJ, Goodman Y, Mattson MP. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res Sep 1 1998;53(5):613-25. (Pubitemid 28380802)
9. Chamorro A, Obach V, Cervera A, Revilla M, Deulofeu R, Aponte JH. Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke. Stroke Apr 2002;33(4):1048-52. (Pubitemid 34293590)
10. Amaro S, Urra X, Gomez-Choco M, Obach V, Cervera A, Vargas M, et al. Uric acid levels are relevant in patients with stroke treated with thrombolysis. Stroke Jan 2011;42(1 Suppl.):S28-32.
11. Logallo N, Naess H, Idicula TT, Brogger J, Waje-Andreassen U, Thomassen L. Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study. BMC Neurol Sep 25 2011;11:114.
12. Dawson J, Lees KR, Weir CJ, Quinn T, Ali M, HennericiMG, et al. Baseline serumurate and 90-day functional outcomes following acute ischemic stroke. Cerebrovasc Dis 2009;28(2):202-3.
13. Karagiannis A, Mikhailidis DP, Tziomalos K, Sileli M, Savvatianos S, Kakafika A, et al. Serum uric acid as an independent predictor of early death after acute stroke. Circ J Jul 2007;71(7):1120-7. (Pubitemid 46998030)
14. Newman EJ, Rahman FS, Lees KR, Weir CJ, Walters MR. Elevated serum urate concentration independently predicts poor outcome following stroke in patients with diabetes. Diabetes Metab Res Rev Jan-Feb 2006;22(1):79-82. (Pubitemid 43154466)
15. Seet RC, Kasiman K, Gruber J, Tang SY, Wong MC, Chang HM, et al. Is uric acid protective or deleterious in acute ischemic stroke? A prospective cohort study. Atherosclerosis Mar 2010;209(1):215-9.
16. Weir CJ, Muir SW, Walters MR, Lees KR. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke Aug 2003;34(8):1951-6. (Pubitemid 36944787)
17. Ginsberg MH, Kozin F, O'Malley M, McCarty DJ. Release of platelet constituents by monosodium urate crystals. J Clin Invest Nov 1977;60(5):999-1007. (Pubitemid 8223125)
18. Grotta J. Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group. Stroke Dec 1997;28(12):2338-46.
19. Adams Jr HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke Jan 1993;24(1):35-41. (Pubitemid 23014379)
20. Kent DM, Selker HP, Ruthazer R, Bluhmki E, Hacke W. The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke. Stroke Dec 2006;37(12):2957-62. (Pubitemid 44900816)
21. Leinonen JS, Ahonen JP, Lonnrot K, Jehkonen M, Dastidar P, Molnar G, et al. Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke Jan 2000;31(1):33-9. (Pubitemid 30035749)
22. Amaro S, Canovas D, Castellanos M, Gallego J, Marti-Febregas J, Segura T, et al. The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute ischaemic stroke patients within the first 4.5 h of onset of symptoms. Int J Stroke Aug 2010;5(4):325-8